Dose-related illusions and hallucinations with zaleplon

Clinical Toxicology

Volumn 46, Issue 4, 2008, Pages 344-345

  Stone, Jason R ^a   Zorick, Todd S ^a   Tsuang, John ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Hallucinations; Hypnotics; Side effects; Zaleplon

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; FLUOXETINE; ZALEPLON; ZIPRASIDONE;

ADULT; BEDTIME DOSAGE; BORDERLINE STATE; DRUG DOSE INCREASE; FEMALE; HALLUCINATION; HUMAN; ILLUSION; INSOMNIA; LETTER; MAJOR DEPRESSION;

ACETAMIDES; ADULT; DEPERSONALIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINATIONS; HUMANS; HYPNOTICS AND SEDATIVES; ILLUSIONS; PYRIMIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 41149147052     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701517442     Document Type: Letter

References (10)

1. Drover D, Lemmens H, Naidu S, Cevallos W, Darwish M, Stanski D. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. Clin Ther 2000; 22:1443-1461.
2. Beer B, Ieni JR, Wu WH, Clody D, Amorusi P, Rose J, Mant T, Gaudreault J, Cato A, Stern W. A placebo-controlled evaluation of single, escalating doses of CL 284, 846, a non-benzodiazepine hypnotic. J Clin Pharmacol 1994; 34:335-334.
3. Rosen AS, Fournié P, Darwish M, Danjou P, Troy SM. Zaleplon pharmacokinetics and absolute bioavailability. Biopharm Drug Dispos 1999; 20: 171-175.
4. King Pharmaceuticals, Wyeth Pharmaceuticals. Sonata® prescribing information, July 2003.
5. Allen D, Curran HV, Lader M. The effects of single doses of CL 284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers. European J Clin Pharmacol 1993; 45:313-320.
6. Bhatia SC. Perceptual disturbances with zaleplon. Psychiatr Serv 2001; 52:109-110.
7. Liskow B, Pikalov A. Zaleplon overdose associated with sleepwalking and complex behavior. J Am Acad Child Adolesc Psychiatry 2004; 43:927-8.
8. Koke SC, Brown EB, Miner CM. Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy. Am J Obstet Gynecol 2002; 29:551-555.
9. Pfizer Inc. Geodon® prescribing information, New York, NY, May 2005.
10. Eli Lilly and Company. Prozac® prescribing information, Indianapolis, IN, January 2005.